Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Zhongan Pharmaceutical is a China-based pharmaceutical manufacturer focused on chemical synthesis active pharmaceutical ingredients and related food-additive products. The company produces mature small-molecule APIs such as caffeine, metronidazole, theophylline, aminophylline, nifedipine, secnidazole, metronidazole benzoate, and xanthinol nicotinate, rather than a novel clinical-stage biotech pipeline. It operates manufacturing facilities in Tianjin and has reported GMP and ISO 9001 certifications, with certain products holding regulatory registrations or certifications including US FDA DMF filings and EU COS documentation. The business appears to be commercially oriented and export-driven, serving international pharmaceutical and beverage customers across multiple regions. It is best characterized as an established API manufacturer in the broader pharmaceutical supply chain rather than a discovery-stage biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Zhongan Pharmaceutical.